Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?

Tirzepatide vs. Semaglutide: Which GLP-1 Is Better?

Both tirzepatide and semaglutide are GLP-1 medications approved for weight loss. But they're not the same, and which one is "better" depends on your individual situation.

Here's the breakdown.

The Mechanism Difference

Semaglutide (Wegovy, Ozempic):

  • Works on GLP-1 receptors only
  • One hormone pathway
  • FDA-approved for weight loss (Wegovy) and diabetes (Ozempic)

Tirzepatide (Zepbound, Mounjaro):

  • Works on GLP-1 AND GIP receptors
  • Two hormone pathways
  • FDA-approved for weight loss (Zepbound) and diabetes (Mounjaro)

The dual-action mechanism of tirzepatide is why it's more potent.

Weight Loss: The Numbers

Clinical trial data (SURMOUNT studies) directly compared the two in patients with obesity:

Semaglutide 2.4mg:

  • Average weight loss: 13.7% of body weight (30-35 lbs)
  • Range: 10-17% depending on dose

Tirzepatide 15mg:

  • Average weight loss: 22.5% of body weight (49-55 lbs)
  • Range: 15-22%+ depending on dose

Difference: Tirzepatide users lost approximately 8-10% MORE body weight.

For a 100kg person:

  • Semaglutide: ~14kg loss
  • Tirzepatide: ~22kg loss

That's an 8kg difference—significant.

Side Effects: Which Is Easier to Tolerate?

Semaglutide:

  • Nausea: Reported in ~50% of users
  • Diarrhoea: ~20%
  • Vomiting: ~10%

Tirzepatide:

  • Nausea: ~65% (more common, likely due to dual action)
  • Diarrhoea: ~23%
  • Vomiting: ~8%

Interestingly, despite more nausea, tirzepatide has similar or slightly lower rates of vomiting. This suggests the nausea is more tolerable than it might sound.

The catch: Both resolve within 2-3 weeks for most people as your body adapts.

Duration & Dosing

Semaglutide:

  • Once-weekly injection
  • Doses: 0.25mg → 2.4mg
  • Reaches therapeutic dose: 16 weeks
  • Can be taken as oral tablet (Rybelsus) — less effective but needle-free

Tirzepatide:

  • Once-weekly injection (only; no oral form available)
  • Doses: 2.5mg → 15mg
  • Reaches therapeutic dose: 16 weeks
  • Only available as injection

Cost (South African Context)

Semaglutide (Wegovy/Ozempic):

  • R3,000-5,000/month (depending on dose)
  • Brand name more expensive

Tirzepatide (Mounjaro/Zepbound):

  • R3,450-6,350/month (depending on dose)
  • Currently only available as brand name in SA

At Rho, we price tirzepatide programmes at R4,200-7,000/month (medication + consultations + support), which is competitive globally.

Long-Term Efficacy: Does One "Stick" Better?

Both medications maintain weight loss as long as you use them. If you stop, weight gradually returns.

However, tirzepatide may have a slight advantage:

  • More aggressive initial weight loss builds momentum
  • Patients see faster results, which improves adherence (people are more likely to stick with something that works quickly)
  • Once at goal weight, you can lower tirzepatide dose and maintain—you don't necessarily need 15mg long-term

Which Is Better for You?

Choose Semaglutide if:

  • You want to minimise nausea risk
  • You prefer oral option (Rybelsus pill available, though less effective)
  • You have any medical reasons semaglutide is preferred (rare)
  • You have insurance coverage for semaglutide specifically

Choose Tirzepatide if:

  • You want maximum weight loss (15-22% vs. 13-17%)
  • You want to reach goal weight faster (motivation-boosting)
  • You have metabolic syndrome or severe insulin resistance (GIP helps with this)
  • You can tolerate mild nausea for 2-3 weeks

The Real-World Difference

Here's what we see in clinical practice:

Semaglutide patients: Steady, predictable weight loss. About 1-1.5 lbs per week. Good for those who prefer slow and steady, or who are very sensitive to side effects.

Tirzepatide patients: Faster initial weight loss (1.5-2 lbs per week initially, slowing after 6-8 weeks). More dramatic transformations. Higher adherence rates because people see dramatic results quickly.

Can You Switch Between Them?

Yes, but it's not typical. If you start on semaglutide and want stronger results, you can switch to tirzepatide after stabilising. Or vice versa if side effects are problematic.

At Rho, we match medication to patient based on goals and tolerance.

The Bottom Line

If you want the most effective weight loss medication currently available, tirzepatide is the evidence-based choice. It's more potent, drives faster results, and has excellent long-term efficacy.

If you're concerned about side effects or prefer a gentler approach, semaglutide is still highly effective and well-tolerated.

At Rho, we prescribe tirzepatide because our patients are serious about results. We support them through dose escalation with anti-nausea medication, dietary guidance, and frequent monitoring. The result: 95% of our patients reach their goal doses and see dramatic transformations.

Not sure which is right for you? Book a consultation with Dr Adè to discuss your individual situation.

Back to blog